Cognito Therapeutics - About the company
Cognito Therapeutics is a series C company based in San Francisco (United States), founded in 2016 by and . It operates as a Developer of a medical device for the treatment of Alzheimer's disease. Cognito Therapeutics has raised $423M in funding from Morningside and FoundersX Ventures. The company has 13 active competitors, including 6 that are funded. Its top competitors include companies like MapHabit, Grey Matter Neurosciences and Sinaptica Therapeutics.
Company Details
Cognito Therapeutics has developed a non-invasive brain stimulation device for the treatment of Alzheimer's disease. The device uses gamma stimulation which helps in reactivating the immune system of the brain. It results in the reduction of amyloid plaques and tau tangles which are typical hallmarks of the disease.
- Website
- Social
Key Metrics
Founded Year
2016
Location
San Francisco, United States
Stage
Series C
Total Funding
in 6 rounds
Latest Funding Round
Investors
Ranked
1st among 13 active competitors
Similar Companies
MapHabit &
Legal entities associated with Cognito Therapeutics
Cognito Therapeutics is associated with 1 legal entity given below:
Legal Entity Name | Date of incorporation | Revenue | Net Profit | Employee Count |
|---|---|---|---|---|
Dec 31, 2015 | - | 141 | 408 |
Get your free copy of Cognito Therapeutics's company profile
Cognito Therapeutics's funding and investors
Cognito Therapeutics has raised a total funding of $423M over 6 rounds. Its first funding round was on 2016.
Cognito Therapeutics has 7 institutional investors including Morningside, FoundersX Ventures and .
Here is the list of recent funding rounds of Cognito Therapeutics:
Date of funding | Funding Amount | Round Name | Post money valuation | Revenue multiple | Investors |
|---|---|---|---|---|---|
Mar 19, 2025 | $196M | Series C | 7513994 | 9974592 | - |
Jun 18, 2024 | $10.2M | Series B | 1039598 | 5833862 | - |
Jan 29, 2024 | $35M | Series B | 3874512 | 2113705 | - |
Access funding benchmarks and valuations. Sign up today!View details of Cognito Therapeutics's funding rounds and investors
Cognito Therapeutics's founders and board of directors
The founders of Cognito Therapeutics are and . is the CEO of Cognito Therapeutics.
View details of Cognito Therapeutics's Founder profiles and Board Members
Cognito Therapeutics's Competitors and alternates
Top competitors of Cognito Therapeutics include MapHabit, Grey Matter Neurosciences and Sinaptica Therapeutics. Here is the list of Top 10 competitors of Cognito Therapeutics, ranked by ÃØÃÜÑо¿Ëù score :
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Overall Rank | Company Details | Short Description | Total Funding | Investors | ÃØÃÜÑо¿Ëù Score |
|---|---|---|---|---|---|
1st | Cognito Therapeutics 2016, San Francisco (United States), Series C | Developer of a medical device for the treatment of Alzheimer's disease | $423M | , WS Investment CompanyÌý&²¹³¾±è;Ìý | 62/100 |
2nd | _1570181853795.png?height=40&width=40){kind=logo} MapHabit 2018, Atlanta (United States), Seed | Provider of app and devices for disabled | - | Georgia Research Alliance, ATDCÌý&²¹³¾±è;Ìý | 49/100 |
3rd | Grey Matter Neurosciences 2021, Toronto (Canada), Seed | Developer of medical devices for neurological disease treatment | $14M | TIAP, Wittington VenturesÌý&²¹³¾±è;Ìý | 48/100 |
4th |  Sinaptica Therapeutics 2022, Cambridge (United States), Seed | Developer of neuromodulation therapy device for Alzheimer's disease | - | 43/100 | |
5th | Functional Neuromodulation 2010, Boston (United States), Seed | Deep Brain Stimulation of the Fornix (DBSf) technology for Alzheimer's disease treatment | $3M | Genesys Capital, Ontario Brain InstituteÌý&²¹³¾±è;Ìý | 40/100 |
6th |  OptoCeutics 2018, Kongens Lyngby (Denmark), Seed | Provider of solutions for treating and diagnosing neurological disease | $2.63M | EIT Health, Ìý&²¹³¾±è;Ìý | 36/100 |
7th |  The Brain Protection Company 2002, Paddington (Australia), Funding Raised | Developer of therapies and diagnostics solutions to manage dementia and Alzheimer’s diseases | - | 34/100 | |
8th |  Oscillo Biosciences 2016, Farmington (United States), Funding Raised | Developer of music-based therapeutic solutions for the treatment of neurological disorders | - | 24/100 | |
9th | _1567681991549.webp?height=40&width=40){kind=logo} YoTeCuido Alzheimer 2016, A Coruna (Spain), Unfunded | App-based platform provider for caregivers and Alzheimer's patients | - | - | 21/100 |
10th | Developer of vibroacoustic therapy for neurological disorders | - | 20/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Cognito Therapeutics's competitors? Click to see the top ones
Cognito Therapeutics's Investments and acquisitions
Cognito Therapeutics has made no investments or acquisitions yet.
Reports related to Cognito Therapeutics
Here is the latest report on Cognito Therapeutics's sector:
View
News related to Cognito Therapeutics
Media has covered Cognito Therapeutics for a total of 11 events in the last 1 year, 8 of them have been about company updates and 2 about people movement.
•
Business Wire•Mar 25, 2025•Cognito Therapeutics
•
Business Wire•Feb 11, 2025•Cognito Therapeutics
•
Business Wire•Nov 19, 2024•Cognito Therapeutics
•
•
MassDevice•Oct 30, 2024•Cognito Therapeutics
•
Business Wire•Oct 29, 2024•Cognito Therapeutics
•
Business Wire•Oct 16, 2024•Cognito Therapeutics
•
Medical Product Outsourcing•Sep 20, 2024•Cognito Therapeutics
•
Business Wire•Jul 29, 2024•Cognito Therapeutics
•
intelligence360•Jul 12, 2024•Cognito Therapeutics
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Frequently asked questions about Cognito Therapeutics
When was Cognito Therapeutics founded?
Cognito Therapeutics was founded in 2016.Where is Cognito Therapeutics located?
Cognito Therapeutics is located in San Francisco, United States.Is Cognito Therapeutics a funded company?
Cognito Therapeutics is a funded company, its first funding round was on 2016.When was the latest funding round of Cognito Therapeutics?
Cognito Therapeutics's latest funding round was on Mar 19, 2025.What is the annual revenue of Cognito Therapeutics?
Annual revenue of Cognito Therapeutics is undefined as on undefined.Our Lite Plan Awaits you - Its Free!
Sign up now to unlock full access to curated data
4M+ Companies- 212K+ Investors
- 580K+ Funding Rounds
- 207K+ Acquisitions
- 2.9K+ Sectors
- 57K+ Business Models
Are you a Founder ?
Explore our recently published companies
- Scrova - Bengaluru based, 2020 founded, Unfunded company
- Makitechindia - Bengaluru based, 2023 founded, Unfunded company
- AMFS Kent - United Kingdom based, 2023 founded, Unfunded company
- Endra - Sweden based, 2024 founded, Unfunded company
- TopperRank - Bengaluru based, 2024 founded, Unfunded company
- DreamStarts - Bengaluru based, 2011 founded, Unfunded company
